Sterofundin
DrugFluid loading
NCT Number: NCT02950974
Prospective, crossover, randomized trial to evaluate plasma compositions after loading dose of sterofundin solution given to healthy volunteer in the resuscitation manner compared with normal saline solution.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
10 healthy volunteers were randomly assigned to receive either normal saline or sterofundin for the first solution in dose of 30 mL/kg (max 2 L) over 1 hour. Blood was collected at baseline (T0), at 60 minutes (T1), 120 minutes (T2), and 240 minutes (T4) from baseline. Time to fist void after initiation of fluid and urine volume were also recorded. After wash-out period of at least 1 week, crossover studies were performed with another fluid.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fluid loading
Fluid loading
Time frame: 4 hours
At 0, 1, 2, and 4 hours from initiation
Time frame: 4 hours
At 0, 1, 2, and 4 hours from initiation
Time frame: 4 hours
At 0, 1, 2, and 4 hours from initiation
Time frame: 4 hours
At 0, 1, 2, and 4 hours from initiation
Time frame: Within 24 hours
Time in minutes from initiation of fluid to first urination
Time frame: Within 24 hours
Volume of first urination in ml
Ramathibodi Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04387552
Behavior, Breast Feeding
Boston, Massachusetts, United States
View Trial DetailsNCT07344376
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Seoul, South Korea
View Trial DetailsNCT01506141
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Chicago, Illinois, United States
View Trial DetailsNCT07032402
Death, Death, Sudden
Antalya, Turkey (Türkiye)
View Trial Details